TPN cholestasis in premature infants: the role of parenteral nutrition solutions.
In conclusion, cholestatic liver disease is a frequent complication in low birthweight infants who receive parenteral nutrition. The etiology of this disorder is probably multifactorial. Although the composition of parenteral nutrition solutions may play a role in the development of cholestasis, at this time, there are limited data to suggest how to change parenteral solutions to alter the course of this disease. Further work is necessary to elucidate therapies to prevent and treat this disorder.
D000596:Amino Acids / Q000009:adverse effects; D002779:Cholestasis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D004734:Energy Metabolism; D005947:Glucose / Q000009:adverse effects; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000209:etiology*; D008055:Lipids / Q000009:adverse effects; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D012306:Risk
D000596:Amino Acids; D008055:Lipids; D005947:Glucose